Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilfried Posch

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
The Journal of Allergy and Clinical Immunology|January 30, 2022
Comparative analyses of IgG/IgA neutralizing effects induced by three COVID-19 vaccines against variants of concernEliott Lafon, Michael Jäger, Angelika Bauer, et al.
Vaccines|September 28, 2021
P80 Natural Essence Exerts Efficient Anti-HIV-1- as Well as Adjuvant Effects in DCsViktoria Zaderer, Wilfried Posch, Ronald Gstir, et al.
Virology Journal|April 21, 2021
Correction to: An in vitro model for assessment of SARS‑CoV‑2 infectivity by defining the correlation between virus isolation and quantitative PCR value: isolation success of SARS‑CoV‑2 from oropharyngeal swabs correlates negatively with Cq valueSissy Therese Sonnleitner, Julian Dorighi, Bianca Jansen, et al.
Respiratory Research|February 28, 2024
P80 natural essence spray and lozenges provide respiratory protection against Influenza A, B, and SARS-CoV-2Viktoria Zaderer, Gabriel Diem, Wilfried Posch, et al.
The Journal of Infectious Diseases|March 4, 2023
Immunity of Heterologously and Homologously Boosted or Convalescent Individuals Against Omicron BA.1, BA.2, and BA.4/5 VariantsMichael Jäger, Gabriel Diem, Sabina Sahanic, et al.
Molecular Medicine (Cambridge, Mass.)|November 23, 2011
Inhibition of human immunodeficiency virus replication by cell membrane-crossing oligomersWilfried Posch, Stefan Piper, Thomas Lindhorst, et al.
Virology Journal|April 8, 2021
An in vitro model for assessment of SARS-CoV-2 infectivity by defining the correlation between virus isolation and quantitative PCR value: isolation success of SARS-CoV-2 from oropharyngeal swabs correlates negatively with Cq valueSissy Therese Sonnleitner, Julian Dorighi, Bianca Jansen, et al.
Journal of Fungi (Basel, Switzerland)|September 23, 2025
Vaginal Clinical Isolates of <i>Candida albicans</i> Differentially Modulate Complosome Activation in Vaginal Epithelial CellsSamyr Kenno, Natalia Pedretti, Luca Spaggiari, et al.
Frontiers in Immunology|July 14, 2022
Immune Responses Against SARS-CoV-2 WT and Delta Variant in Elderly BNT162b2 VaccineesMichael Jäger, Sissy Therese Sonnleitner, Stefanie Dichtl, et al.
The Journal of Infectious Diseases|September 10, 2025
The Role of Enoxaparin in Influenza Virus Infections and Its Therapeutic ImplicationsMarta Bermejo-Jambrina, Viktoria Zaderer, Julia Eder, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
The Journal of Allergy and Clinical Immunology|January 30, 2022
Comparative analyses of IgG/IgA neutralizing effects induced by three COVID-19 vaccines against variants of concernEliott Lafon, Michael Jäger, Angelika Bauer, et al.
Vaccines|September 28, 2021
P80 Natural Essence Exerts Efficient Anti-HIV-1- as Well as Adjuvant Effects in DCsViktoria Zaderer, Wilfried Posch, Ronald Gstir, et al.
Virology Journal|April 21, 2021
Correction to: An in vitro model for assessment of SARS‑CoV‑2 infectivity by defining the correlation between virus isolation and quantitative PCR value: isolation success of SARS‑CoV‑2 from oropharyngeal swabs correlates negatively with Cq valueSissy Therese Sonnleitner, Julian Dorighi, Bianca Jansen, et al.
Respiratory Research|February 28, 2024
P80 natural essence spray and lozenges provide respiratory protection against Influenza A, B, and SARS-CoV-2Viktoria Zaderer, Gabriel Diem, Wilfried Posch, et al.
The Journal of Infectious Diseases|March 4, 2023
Immunity of Heterologously and Homologously Boosted or Convalescent Individuals Against Omicron BA.1, BA.2, and BA.4/5 VariantsMichael Jäger, Gabriel Diem, Sabina Sahanic, et al.
Molecular Medicine (Cambridge, Mass.)|November 23, 2011
Inhibition of human immunodeficiency virus replication by cell membrane-crossing oligomersWilfried Posch, Stefan Piper, Thomas Lindhorst, et al.
Virology Journal|April 8, 2021
An in vitro model for assessment of SARS-CoV-2 infectivity by defining the correlation between virus isolation and quantitative PCR value: isolation success of SARS-CoV-2 from oropharyngeal swabs correlates negatively with Cq valueSissy Therese Sonnleitner, Julian Dorighi, Bianca Jansen, et al.
Journal of Fungi (Basel, Switzerland)|September 23, 2025
Vaginal Clinical Isolates of <i>Candida albicans</i> Differentially Modulate Complosome Activation in Vaginal Epithelial CellsSamyr Kenno, Natalia Pedretti, Luca Spaggiari, et al.
Frontiers in Immunology|July 14, 2022
Immune Responses Against SARS-CoV-2 WT and Delta Variant in Elderly BNT162b2 VaccineesMichael Jäger, Sissy Therese Sonnleitner, Stefanie Dichtl, et al.
The Journal of Infectious Diseases|September 10, 2025
The Role of Enoxaparin in Influenza Virus Infections and Its Therapeutic ImplicationsMarta Bermejo-Jambrina, Viktoria Zaderer, Julia Eder, et al.
Pageof 9